A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 2005

Conditions
HIV Infections
Interventions
BIOLOGICAL

Tetanus Toxoid Vaccine

BIOLOGICAL

Hepatitis A Vaccine (Inactivated)

BIOLOGICAL

HIV-1 Immunogen

BIOLOGICAL

Hepatitis B Vaccine (Recombinant)

Trial Locations (2)

52242

Univ. of Iowa Healthcare, Div. of Infectious Diseases, Iowa City

Unknown

NY Univ. HIV/AIDS CRS, New York

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000943 - A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328 | Biotech Hunter | Biotech Hunter